Close

Leerink Partners Raises Price target on Magellan Health (MGLN) Following 3Q and Guidance

Go back to Leerink Partners Raises Price target on Magellan Health (MGLN) Following 3Q and Guidance

Magellan Health Provides 2017 Financial Guidance

November 22, 2016 6:30 AM EST

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) today announced that in 2017, it expects to generate net revenue in the range of $5.8 billion to $6.1 billion, and net income in the range of $90 million to $114 million, which translates into diluted earnings per share (EPS) in the range of $3.80 to $4.81. Adjusted net... More

Magellan Health to Acquire Veridicus Holdings, LLC

November 21, 2016 6:30 AM EST

SCOTTSDALE, Ariz.--(BUSINESS WIRE)-- Magellan Health, Inc. (NASDAQ: MGLN) today announced that it has entered into an agreement to acquire Veridicus Holdings, LLC, a privately held pharmacy benefit management (PBM) organization with a unique set of clinical services and capabilities. Veridicus differentiated approach to pharmacy management leverages proprietary analytics and clinical software that integrates pharmacy, medical and... More